 |
인쇄하기
취소
|
LG Life Sciences develops innovative cytoprotective agent
LG Life Sciences Ltd. said on October 27 it will carry out the phase 1 clinical study of a drug for the treatment of stroke and myocardial infarction, in collaboration with Asan Medical Center.
The company said it had successfully completed an animal experiment on Cytopro, a novel cytoprotective agent.
LG officials said Cytopro has great potential treating liver disease, degenerative cere...
The company said it had successfully completed an animal experiment on Cytopro, a novel cytoprotective agent.
LG officials said Cytopro has great potential treating liver disease, degenerative cere...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.